Fulltext:
229081.pdf
Embargo:
until further notice
Size:
351.6Kb
Format:
PDF
Description:
Publisher’s version
Publication year
2020Source
Nederlands Tijdschrift voor Geneeskunde, 164, (2020), article D5475ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Clinical Pharmacy
Internal Medicine
Pharmacology-Toxicology
Journal title
Nederlands Tijdschrift voor Geneeskunde
Volume
vol. 164
Subject
Radboudumc 18: Healthcare improvement science RIHS: Radboud Institute for Health Sciences; Radboudumc 4: lnfectious Diseases and Global Health RIHS: Radboud Institute for Health Sciences; Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life Sciences; Clinical Pharmacy - Radboud University Medical Center; Internal Medicine - Radboud University Medical Center; Pharmacology-Toxicology - Radboud University Medical CenterAbstract
In March the CEO of Tesla, Elon Musk, posted a Tweet about the possible effects of chloroquine for COVID-19. Celebrities and mainstream media joined the discussion and promoted (hydroxy-)chloroquine to a true hype and the miracle cure for COVID-19. Police surveillance was needed to protect the producer of chloroquine in the Netherlands. Was (hydroxy-)chloroquine just a hype? The first European study had many methodological issues, a misleading conclusion and was published without the peer review process. It took several weeks before better designed studies showed that (hydroxy-)chloroquine was not effective for COVID-19, after which the use of this medicine was no longer recommended. It is understandable that in a pandemic there is a high need for an effective cure, but physicians should have waited until effectiveness was demonstrated. In our opinion, the use of (hydroxy-)chloroquine for COVID-19 was indeed a hype.
This item appears in the following Collection(s)
- Academic publications [246625]
- Electronic publications [134196]
- Faculty of Medical Sciences [93367]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.